RETRACTED: Proteome-driven transcriptomic dissection of EMT networks in bladder cancer based on the VIM and CDH2 protein macromolecules influence: From molecular-protein subtyping to therapeutic target prioritization
Authors:
- 24 May 2025
- journal article
- retracted article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 315, 144585
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Update on Epithelial-Mesenchymal Plasticity in Cancer ProgressionAnnual Review of Pathology: Mechanisms of Disease, 2024
- POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancerThe FASEB Journal, 2023
- Bladder cancerNature Reviews Disease Primers, 2023
- Regulation of cisplatin resistance in bladder cancer by epigenetic mechanismsDrug Resistance Updates, 2023
- CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancerCancer Letters, 2022
- Vimentin and cytokeratin: Good alone, bad togetherSeminars in Cancer Biology, 2022
- Autophagy and EMT in cancer and metastasis: Who controls whom?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
- Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancerInternational Journal of Cancer, 2021
- Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancerThe Lancet Oncology, 2021
- Bladder CancerJAMA, 2020